Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

Similar articles for PubMed (Select 23280200)

1.

Studies suggest potential approaches for early detection of Alzheimer disease.

Friedrich MJ.

JAMA. 2013 Jan 2;309(1):18-9. doi: 10.1001/jama.2012.105106. No abstract available.

PMID:
23280200
2.

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.

Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A.

Brain. 2011 Jan;134(Pt 1):301-17. doi: 10.1093/brain/awq349. Epub 2010 Dec 13.

3.

[Markers of prodromal Alzheimer's disease].

de Souza LC, Sarazin M, Uspenskaya O, Habert MO, Lamari F, Lehéricy S, Dubois B.

Rev Neurol (Paris). 2012 Nov;168(11):815-24. doi: 10.1016/j.neurol.2012.07.005. Epub 2012 Sep 1. Review. French.

PMID:
22944619
4.

The role of biomarkers in clinical trials for Alzheimer disease.

Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, Zetterberg H, Galasko D, Praticò D, Griffin S, Schenk D, Siemers E.

Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):6-15. Review.

5.

Biomarkers: warning signs.

Williams R.

Nature. 2011 Jul 13;475(7355):S5-7. doi: 10.1038/475S5a. No abstract available.

PMID:
21760581
6.

Early Alzheimer's disease diagnosis gives hope. Detection in initial stages could slow progression, perhaps lead to prevention.

[No authors listed]

Duke Med Health News. 2006 Nov;12(11):3-4. No abstract available.

PMID:
17225302
7.

Advances in structural and molecular neuroimaging in Alzheimer's disease.

Ellis KA, Rowe CC, Szoeke CE, Villemagne VL, Ames D, Chételat G, Martins RN, Masters CL, Fripp J, Acosta O, Raniga P, Bourgeat PT, Salvado O.

Med J Aust. 2011 Feb 21;194(4):S20-3.

PMID:
21401483
8.

Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer disease.

Rabinovici GD, Roberson ED.

Ann Neurol. 2010 Mar;67(3):283-5. doi: 10.1002/ana.22020. No abstract available.

PMID:
20373338
9.

[Imaging diagnosis of Alzheimer's disease].

Mänz C, Reimold M, Bender B, Bares R, Ernemann U, Horger M.

Rofo. 2012 Dec;184(12):1079-82. doi: 10.1055/s-0032-1319030. Epub 2012 Dec 4. Review. German. No abstract available.

PMID:
23212812
10.

Alzheimer disease: before the diagnosis.

Roe CM, Rentz DM.

Neurology. 2013 Mar 26;80(13):e148-9. doi: 10.1212/WNL.0b013e31828cade3. No abstract available.

PMID:
23530160
11.

Mapping out biomarkers for Alzheimer disease.

Breteler MM.

JAMA. 2011 Jan 19;305(3):304-5. doi: 10.1001/jama.2010.2017. No abstract available.

PMID:
21245188
12.

Amyloid-β imaging with PET in Alzheimer's disease: is it feasible with current radiotracers and technologies?

Moghbel MC, Saboury B, Basu S, Metzler SD, Torigian DA, Långström B, Alavi A.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):202-8. doi: 10.1007/s00259-011-1960-4. No abstract available.

PMID:
22009379
13.

[Discovery and characteristic of surrogate marker for Abeta42 production-possibility of diagnosis marker as pre-Alzheimer condition].

Okochi M, Tagami S, Yanagida K, Takeda M.

Seishin Shinkeigaku Zasshi. 2013;115(3):245-52. Japanese. No abstract available.

PMID:
23991472
14.

The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.

Blennow K, Zetterberg H.

Med Clin North Am. 2013 May;97(3):369-76. doi: 10.1016/j.mcna.2012.12.012. Epub 2013 Feb 1. Review.

PMID:
23642576
15.

Imaging agents that identify Alzheimer's disease on the way.

Morrow T.

Manag Care. 2011 May;20(5):49-50. No abstract available.

16.

Biomarkers for early detection of Alzheimer pathology.

Clark CM, Davatzikos C, Borthakur A, Newberg A, Leight S, Lee VM, Trojanowski JQ.

Neurosignals. 2008;16(1):11-8. Epub 2007 Dec 5. Review.

17.

In vivo characterization of the early states of the amyloid-beta network.

Sepulcre J, Sabuncu MR, Becker A, Sperling R, Johnson KA.

Brain. 2013 Jul;136(Pt 7):2239-52. doi: 10.1093/brain/awt146.

18.

Peering inside Alzheimer's brains.

Sinha G.

Nat Biotechnol. 2011 May;29(5):384-7. doi: 10.1038/nbt.1863. No abstract available.

PMID:
21552232
19.

The utility of the new research diagnostic criteria for Alzheimer's disease.

Dubois B, Gauthier S, Cummings J.

Int Psychogeriatr. 2013 Feb;25(2):175-7. doi: 10.1017/S1041610212002098. Epub 2012 Nov 13. No abstract available.

PMID:
23148941
20.

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.

Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL; AIBL Research Group.

Brain. 2012 Jul;135(Pt 7):2126-39. doi: 10.1093/brain/aws125. Epub 2012 May 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk